Loading insider details...
Beta
Latest Form 4 (Jul 16, 2026): Purchase of 34,364 CRDF shares, $50.0K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jul 16, 2026 | Cardiff Oncology, Inc. (CRDF) | Purchase | 34,364 | $50.0K |
| Jun 22, 2026 | CytomX Therapeutics, Inc. (CTMX) | Grant/Award | 59,000 | n/a |
| Jun 22, 2026 | Cardiff Oncology, Inc. (CRDF) | Purchase | 24,703 | $29.9K |
| Apr 2, 2026 | Cardiff Oncology, Inc. (CRDF) | Grant/Award | 600,000 | n/a |
| Feb 18, 2026 | Cardiff Oncology, Inc. (CRDF) | Grant/Award | 200,000 | n/a |
| Jun 30, 2025 | Cardiff Oncology, Inc. (CRDF) | Grant/Award | 40,565 | n/a |
| Jun 13, 2025 | CytomX Therapeutics, Inc. (CTMX) | Grant/Award | 38,000 | n/a |
| Jul 1, 2024 | Cardiff Oncology, Inc. (CRDF) | Grant/Award | 29,700 | n/a |
| May 17, 2024 | CytomX Therapeutics, Inc. (CTMX) | Grant/Award | 38,000 | n/a |
| Jun 20, 2023 | Cardiff Oncology, Inc. (CRDF) | Grant/Award | 27,700 | n/a |